Clinical Trial Update: Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update of cabozantinib with or without trastuzumab in breast cancer patients with brain metastases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Brain Tumor - Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2021-05-18